SeƱora, Charylette B.
HRN: 02-92-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2025
CEFTRIAXONE 1G (VIAL)
08/04/2025
08/11/2025
IV
1g
OD
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: